- Current report filing (8-K)
January 07 2013 - 9:00AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January
7, 2013
MAKO Surgical Corp.
(Exact name of registrant as specified in its charter)
Delaware
|
001-33966
|
20-1901148
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
2555 Davie Road
Fort Lauderdale, Florida 33317
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area
code:
(954) 927-2044
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02. Results of Operations and Financial Condition.
On January 7, 2013, MAKO Surgical Corp. (the “
Company
”)
issued a press release (the “
Press Release
”) announcing for the fourth quarter and full year 2012 the number
of RIO® Robotic Arm Interactive Orthopedic Systems sold, the number of MAKOplasty® Total Hip Arthroplasty (THA) applications
sold, the percentage of domestic commercial installed base having the MAKOplasty THA application, and the number of MAKOplasty
procedures performed. The foregoing description of the Press Release does not purport to be complete and is qualified in its entirety
by reference to the full text of the Press Release, a copy of which is furnished herewith as Exhibit 99.1 and is incorporated into
this Form 8-K by reference.
The information in this Form 8-K and the exhibit attached hereto pertaining
to the Company’s operating results shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference
in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such
filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
|
|
Description of Exhibit
|
|
|
|
99.1
|
|
Press Release issued by MAKO Surgical Corp. on January 7, 2013
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
MAKO Surgical Corp.
|
|
|
|
|
|
|
|
|
|
Date: January 7, 2013
|
By:
|
/s/ Fritz L. LaPorte
|
|
|
Fritz L. LaPorte, Senior Vice President
of Finance and Administration, Chief
Financial Officer and Treasurer
|
EXHIBIT INDEX
Exhibit No.
|
|
Description of Exhibit
|
|
|
|
99.1
|
|
Press Release issued by MAKO Surgical Corp. on January 7, 2013
|
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From May 2024 to Jun 2024
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jun 2023 to Jun 2024